An observational study in COVID-19, sponsored by Mahidol University. Completed at 1 site in Thailand. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-19.
Sponsored by Mahidol University · Observational
The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.
The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.
7,775 studies on the registry are indexed under COVID-19; 482 are open to participants now.
This study's enrollment of 5,181 is above the median of 260 across 3,188 observational studies indexed under COVID-19.
Browse COVID-19 studies →Mahidol University is the lead sponsor of 744 studies on the registry; 116 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The COVID-19 patients who confirmed by RT-PCR at Siriraj hospital since July 8, 2021 with mild to moderate symptoms and isolated in patients' own home so-called "Siriraj Home isolation".
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1. people who received additional vaccination after leaving quarantine before the day of the immunization test
Anti-SARS-CoV-2 RBD IgG
Anti-RBD IgG (BAU/mL)
Time frame: Baseline
Anti-SARS-CoV-2 NP
Anti-SARS-CoV-2 NP (PRNT50 titer)
Time frame: Baseline
Cycle threshold of the first PCR test
Cycle threshold (Ct)
Time frame: Baseline
Number of vaccine injection
Number of vaccine injection
Time frame: Baseline
Type of vaccine injection
Type of vaccine injection
Time frame: Baseline
Ran from Nov 2021 to primary completion in Mar 2022, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.